Abstract:Management of moderate to severe pain relies heavily on opioid analgesics such as morphine, oxycodone, and fentanyl in clinics. However, their prolonged use was associated with undesirable side effects. Many new strategies to reduce side effects have been proposed, but not without disadvantages. Using a hot plate model as a phenotypic screening method, our studies identified (3R,4S)-9d with a new scaffold as a potent analgesic with ED50 values of 0.54 mg/kg and 0.021 mg/kg in hot plate and antiwrithing models, respectively. Mechanistic studies showed that it elicited its analgesic effect via the active metabolite (3R,4S)-10a. The mechanism of (3R,4S)-10a-induced activation of the μ opioid receptor (MOR) was proposed by means of molecular dynamics (MD) simulation.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00722?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00722</a>.Active murine MOR, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M">5C1M</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00722/suppl_file/jm1c00722_si_001.pdb">PDB</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00722/suppl_file/jm1c00722_si_002.csv">CSV</a>)Screening of resolution of 4c; optimization of the resolution procedure of 4c; HPLC spectrum of 4c and its enantiomers; experimental and theoretical ECD; In vivo metabolism assay; potential energy and RMSD evolution during MD simulation; 1H NMR and 13C NMR spectra of final compounds; HPLC spectra of key compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00722/suppl_file/jm1c00722_si_003.pdf">PDF</a>)This article has not yet been cited by other publications.

Synthesis, Crystal Structure, and Antinociceptive Effects of Some New Riluzole Derivatives

Preparation and in Vivo Antinociceptive Behavior of Four New 2‐amino‐6‐trifuromethoxybenzothiazole Carboxylic Acid Derivatives

Antitumor Activity and Mechanism Study of Riluzole and Its Derivatives

Discovery, Structure–Activity Relationship, and Mechanistic Studies of 1-((3 R ,4 S )-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic

Synthesis and biological evaluation of N-(benzene sulfonyl)acetamide derivatives as anti-inflammatory and analgesic agents with COX-2/5-LOX/TRPV1 multifunctional inhibitory activity

Design and Synthesis of Novel Α-Aminoamides Derivatives As Nav1.7 Inhibitors for Antinociception

Novel 1-Oxyl-2-substitutedphenyl-4,4,5,5-tetramethylimidazolines: Synthesis, Selectively Analgesic Action, and QSAR Analysis

Synthesis and Biological Activity of 5-Chloro-3-(hydroxy-p-methanesulfonylphenylmethylene)-2-oxo-2,3-dihydroi Ndole-1-Carboxamides

Synthesis of Substituted 5-Amino-3-(R-carbonyl)-1-(2-oxoethylidene)-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e]pyrrolo[1,2-a]pyrimidin-2(1H)-ones with Antinociceptive Activity

Synthesis and Anti-inflammatory Analgesic Activities of 2-(2,6-dichlorophenylamino)-benzeneacetic Acid(3-nitroxymethyl) Phenyl Ester

Synthesis and Structure–Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents

Synthesis and Biological Activity of Novel L-Amino Acid Based Analgesic Compounds

Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy

Design, synthesis, and in silico studies of novel eugenyloxy propanol azole derivatives having potent antinociceptive activity and evaluation of their β-adrenoceptor blocking property

Synthesis and Anti-Inflammatory Activity Evaluation of Novel 3-Alkyl-6-(4h-1,2,4-triazol-4-yl)-3,4-dihydro-2h-benzo[e][1,3]oxazine Derivatives

Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.

Synthesis and Structure-Activity Relationships of 5-Aryl-14-alkoxypyridomorphinans: Identification of a Opioid Receptor Agonist/ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects

Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a Mu Opioid Receptor Agonist/Delta Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.

Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.

[Synthesis and Analgesic Activities of Phenyl Piperazinyl Aralkyl Ketone Derivatives].

Synthesis of Carbamide Derivatives Bearing Tetrahydroisoquinoline Moieties and Biological Evaluation As Analgesia Drugs in Mice